| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President-protein Sciences | Director | SVP - Novus Biologicals +1 more
2 companies
Eansor Norman David is a Director at MRKR, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 30 sales. Those positions are worth an estimated $265K at current prices.
Our model assigns Eansor Norman David a middling insider score of 52/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of -4.7%.
Eansor Norman David's largest disclosed position is in TECH as President-protein Sciences, worth about $265K. The recent filings there lean toward selling, a net 102,264 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 | TECH Bio-Techne Corp | President-protein Sciences | Sale+OE | 27,159 | $504.00 | $13,688,192.94 | -95.4% | -16.1% | -30.4% | |
| Aug 31, 2021 | TECH Bio-Techne Corp | President-protein Sciences | Sell | 1,538 | $503.07 | $773,727.66 | -53.9% | -3.8% | -33.3% | |
| Mar 16, 2021 | MRKR Marker Therapeutics, Inc. | Director | Buy | 14,285 | $17.50 | $249,987.50 | +588.3% | +91.4% | -77.7% | |
| Feb 5, 2021 | TECH Bio-Techne Corp | President-protein Sciences | Sale+OE | 32,933 | $380.68 | $12,537,022.91 | -96.2% | - | - | |
| May 29, 2020 | TECH Bio-Techne Corp | President-protein Sciences | Sale+OE | 11,357 | $261.45 | $2,969,274.09 | -100% | - | - | |
| May 22, 2020 | TECH Bio-Techne Corp | President-protein Sciences | Sale+OE | 23,637 | $267.73 | $6,328,241.62 | -100% | - | - | |
| Mar 4, 2020 | TECH Bio-Techne Corp | President-protein Sciences | Sell | 1,387 | $198.68 | $275,569.16 | -100% | - | - | |
| Jun 12, 2019 | TECH Bio-Techne Corp | SVP - Novus Biologicals | Sell | 3,117 | $215.00 | $670,155.00 | -100% | - | - | |
| May 4, 2018 | TECH Bio-Techne Corp | SVP - Novus Biologicals | Sell | 1,136 | $145.19 | $164,931.75 | -33.4% | - | - |